sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Mek162

Mek162

CAS No.:
606143-89-9
Catalog Number:
AG0039DV
Molecular Formula:
C17H15BrF2N4O3
Molecular Weight:
441.2268
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%(HPLC)
In Stock USA
United States
$122
- +
10mg
98%(HPLC)
In Stock USA
United States
$211
- +
Product Description
Catalog Number:
AG0039DV
Chemical Name:
Mek162
CAS Number:
606143-89-9
Molecular Formula:
C17H15BrF2N4O3
Molecular Weight:
441.2268
MDL Number:
MFCD22124525
IUPAC Name:
6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
InChI:
InChI=1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)
InChI Key:
ACWZRVQXLIRSDF-UHFFFAOYSA-N
SMILES:
OCCONC(=O)c1cc2n(C)cnc2c(c1Nc1ccc(cc1F)Br)F
UNII:
181R97MR71
Properties
Complexity:
521  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
440.03g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
441.233g/mol
Monoisotopic Mass:
440.03g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
88.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.1  
Literature
Title Journal
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial. The Lancet. Oncology 20180501
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. The Lancet. Oncology 20130301
Properties